IGC · Insider Trading
IGC Pharma, Inc.
Every open-market purchase and sale reported by IGC officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-29 | Claudia Grimaldi | PFO | G | −150,000 | — |
| 2026-09-29 | Ram Mukunda | CEO | G | −200,000 | — |
| 2026-07-01 | Ram Mukunda | CEO | A | +2,226,475 | +$601.15K |
| 2026-07-01 | Claudia Grimaldi | PFO | A | +2,048,378 | +$553.06K |
| 2026-04-06 | James P Moran | Director | M | +130,000 | — |
| 2026-04-06 | Ram Mukunda | CEO | M | +706,409 | +$84.00K |
| 2026-04-06 | Richard K Prins | Director | M | +170,000 | — |
| 2026-04-06 | Claudia Grimaldi | PFO | M | +238,462 | +$36.00K |
| 2026-02-04 | Ram Mukunda | CEO | M | +50,000 | — |
| 2026-01-20 | Richard K Prins | Director | M | +100,000 | — |
| 2025-10-22 | Richard K Prins | Director | A | +750,000 deriv. | — |
| 2025-10-21 | James P Moran | Director | A | +500,000 deriv. | — |
| 2025-10-21 | Claudia Grimaldi | PFO | G | −50,000 | — |
| 2025-10-21 | Terry L Lierman | Director | A | +500,000 deriv. | — |
| 2025-10-20 | Ram Mukunda | CEO | G | −100,000 | — |
| 2024-09-27 | James P Moran | Director | Buy | +588,235 | +$200.00K |
| 2024-08-12 | Richard K Prins | Director | G | −200,000 | — |
| 2024-05-13 | Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857) | 10%+ Owner | A | +8,823,529 | +$3.00M |
| 2024-03-18 | Ram Mukunda | CEO | MIXED | +984,585 | — |
| 2024-03-15 | Terry L Lierman | Director | A | +150,000 deriv. | — |
| 2024-03-15 | James P Moran | Director | M | +220,834 | — |
| 2024-03-15 | Claudia Grimaldi | Director | M | +336,666 | — |
| 2024-03-15 | Richard K Prins | Director | M | +329,583 | — |
| 2023-06-28 | James P Moran | Director | M | +83,334 | — |
| 2023-06-28 | Claudia Grimaldi | VICE PRESIDENT, CCO & PF0 | M | +141,667 | — |
| 2023-06-27 | Richard K Prins | Director | M | +158,334 | — |
| 2023-06-27 | Ram Mukunda | CEO | MIXED | +200,001 | — |
| 2022-06-28 | John Edward LYNCH | Director | M | +37,500 | — |
| 2022-06-28 | Richard K Prins | Director | M | +225,000 | — |
| 2022-06-28 | Claudia Grimaldi | VICE PRESIDENT & PF0 | M | +120,834 | — |
| 2022-06-28 | Ram Mukunda | CEO | M | +1,150,001 | — |
| 2022-01-28 | James P Moran | Director | A | +150,000 | — |
| 2021-12-27 | Richard K Prins | Director | MIXED | +260,000 | — |
| 2021-12-23 | Ram Mukunda | CEO | A | — | — |
| 2021-12-23 | Claudia Grimaldi | Vice President & PFO | A | +250,000 | — |
| 2021-09-15 | Ram Mukunda | CEO | A | +1,050,000 | — |
| 2021-05-19 | Rohit Goel | Senior Director of Finance&PAO | A | +75,000 | — |
| 2021-05-14 | Richard K Prins | Director | A | +300,000 | — |
| 2021-05-14 | Ram Mukunda | CEO | A | +1,050,000 | — |
| 2021-03-10 | Richard K Prins | Director | Sell | −50,000 | −$87.50K |
| 2021-03-08 | Richard K Prins | Director | MIXED | −75,000 | −$90.00K |
| 2021-03-08 | Ram Mukunda | Exec. Chairman & CEO | Sell | −50,000 | −$107.00K |
| 2020-12-04 | Richard K Prins | Director | MIXED | −143,000 | −$102.00K |
| 2020-12-02 | Ram Mukunda | Exec. Chairman & CEO | MIXED | −600,000 | −$187.02K |
| 2020-06-15 | Rohit Goel | Manager and PAO | A | +30,000 | — |
| 2019-06-12 | Rohit Goel | Manager and PAO | A | +30,000 | — |
| 2019-06-12 | Ram Mukunda | Exec. Chairman & CEO | A | +750,000 | — |
| 2019-06-12 | Claudia Grimaldi | Vice President & PFO | A | +300,000 | — |
| 2019-06-12 | Sudhakar V Shenoy | Director | MIXED | −350,000 | — |
| 2019-06-12 | Richard K Prins | Director | MIXED | +400,000 | −$54.00K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Ram Mukunda | CEO | 7,652,982 | $1.86M |
| Claudia Grimaldi | PFO | 3,271,092 | $793.24K |
| James P Moran | Director | 2,128,137 | $516.07K |
| Richard K Prins | Director | 1,541,251 | $373.75K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the IGC quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.